Renaissance IPO ETF (NY:IPO)

53.59 UNCHANGED

Delayed Quote Updated: 8:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Renaissance IPO ETF

< Previous 1 2 3 4 5 6 Next >

Oncology-Focused Biotech Immuneering Jumps To Wall Street With $112M IPO ↗

July 30, 2021

Immuneering Corp (NASDAQ: IMRX) has kept a relatively low profile since launching with $17 million back in 2019. That is until it landed another $62 million ...

Via Benzinga

Omega Therapeutics Kicks Start Trading On NASDAQ ↗

July 30, 2021

On the heels of a $126 million crossover round in March, Flagship Pioneering-backed Omega Therapeutics Inc (NASDAQ: OMGA) has priced a $125.8 million IPO to take...

Via Benzinga

Topics Initial Public Offering

London-Listed MaxCyte Makes NASDAQ Debut Today ↗

July 30, 2021

MaxCyte Inc (NASDAQ: MXCT) is already trading on London’s AIM, but now, it debuted on NASDAQ after pricing a $176 million IPO at $13 apiece, on the higher end of...

Via Benzinga

Topics Initial Public Offering

Riskified Raises $363M Via IPO At $21 Per Share, Trading Begins Today ↗

July 29, 2021

Fraud management platform Riskified Ltd (NYSE: RSKD) priced 17.5 million shares at $21 per share in its initial public offering. Riskified offered 17.3...

Via Benzinga

Topics Fraud Initial Public Offering

PowerSchool Raises $710.5M Via IPO At $18 Per Share, Trading Begins Today ↗

July 28, 2021

The cloud-based software provider for K-12 education in North America PowerSchool Holdings, Inc, (NYSE: PWSC) priced 39.5 million shares at $18 per share in its ...

Via Benzinga

Topics Initial Public Offering

Snap One Prices IPO At Lower End Of Estimated Range, Trading Begins Today ↗

July 28, 2021

Smart living products, services, and software provider Snap One Holdings Corp (NASDAQ: SNPO) priced 13.85 million shares at $18 per share in its initial public...

Via Benzinga

Topics Initial Public Offering

MeridianLink Raises $260M Via Upsized IPO At $26 Per Share, Trading Begins Today ↗

July 28, 2021

Cloud-based technology company MeridianLink, Inc (NYSE: MLNK) priced 13.2 million shares at $26 per share in its upsized initial public offering. The company...

Via Benzinga

Topics Initial Public Offering

Duolingo Prices IPO Above Estimated Price At $102 Per Share, Trading Begins Today ↗

July 28, 2021

Mobile language learning platform Duolingo, Inc (NASDAQ: DUOL) priced 3.7 million shares at $102 per share in its initial public offering. The estimated gross proceeds...

Via Benzinga

Topics Initial Public Offering

Visa-Backed Conductor Prepares for US IPO: Reuters ↗

July 27, 2021

Visa Inc (NYSE: V) backed Brazilian payments firm Conductor has hired banks for a U.S. initial public offering that could occur as early as 2021, Reuters reports....

Via Benzinga

Language Learning App Duolingo Could Be Valued Over $4.6B Based On Upsized IPO: Reuters ↗

July 26, 2021

Duolingo Inc (NASDAQ: DUOL) proposed to sell 5.1 million shares at between $95 - $100 each in its upsized U.S. initial public offering, Reuters reports. The hike...

Via Benzinga

Cell Analysis Instruments Provider Cytek Biosciences Kick Starts Trading After Pricing IPO At $17 ↗

July 23, 2021

Cytek Biosciences Inc (NASDAQ: CTKB) shares started trading today after its initial public offering was priced to raise about $200 million for the cell-analysis Company....

Via Benzinga

Topics Initial Public Offering

Xponential Fitness Prices Downsized IPO Below Expected Range ↗

July 23, 2021

Xponential Fitness Inc (NYSE: XPOF), a fitness franchiser, has announced the pricing of its initial public offering (IPO) of 10 million shares at $12 per ordinary...

Via Benzinga

Topics Initial Public Offering

Outbrain Prices IPO Below Expected Range; Trading Begins Today ↗

July 23, 2021

Open web recommendation platform Outbrain Inc (NASDAQ: OB) priced 8 million shares at $20 per share in its initial public offering. It earlier expected to price...

Via Benzinga

Topics Initial Public Offering

Gambling.com Prices IPO At Lower End Of Expected Range ↗

July 23, 2021

Gambling.com Group Ltd (NASDAQ: GAMB), a digital marketing services provider, has announced the pricing of its initial public offering (IPO) of 5.25 million shares...

Via Benzinga

Topics Initial Public Offering

AI-based Healthcare Data Analytics Platform Provider Sophia Genetics Makes Its Wall Street Debut: What You Need to Know ↗

July 23, 2021

Switzerland-based Sophia Genetics SA (NASDAQ: SOPH), a healthcare tech company, is debuting on Wall Street Friday. Here is what you should know about the company. Sophia...

Via Benzinga

Instructure Holdings Raises $250M Via IPO At $20 Per Share, Trading Begins Today ↗

July 22, 2021

Education technology company Instructure Holdings Inc (NYSE: INST) priced 12.5 million shares at $20 per share in its initial public offering. It earlier...

Via Benzinga

Topics Initial Public Offering

Zenvia Raises $150M Via IPO At $13 Per Share ↗

July 22, 2021

Customer experience communications platform Zenvia Inc (NASDAQ: ZENV) priced 11.5 million shares at $13 per share in its initial public offering. The...

Via Benzinga

Topics Initial Public Offering

VTEX Raised $264M Via IPO At $19 Per Share, Trading Begins Today ↗

July 21, 2021

Software-as-a-service digital commerce platform provider VTEX (NYSE: VTEX) priced 19 million shares at $19 per share in its initial public offering. The...

Via Benzinga

Topics Initial Public Offering

Paycor HCM Raised $425.5M Via IPO At $23 Per Share, Trading Begins Today ↗

July 21, 2021

Human Capital Management (HCM) software creator Paycor HCM Inc (NASDAQ: PYCR) priced 18.5 million shares at $23 per share in its initial public offering. The...

Via Benzinga

Topics Initial Public Offering

Nervous System Firm Eliem Therapeutics Files For $80M IPO ↗

July 19, 2021

Eliem Therapeutics (NASDAQ: ELYM), a Phase 2a biotech developing therapies for neuronal excitability disorders, filed an IPO prospectus with the SEC to raise up to $80...

Via Benzinga

Topics Initial Public Offering Regulatory Compliance

Skin-Disease Focused Biotech Castle Creek Files $100M IPO ↗

July 19, 2021

Ahead of Phase 3 data readout in the second half of next year, Castle Creek Biosciences Inc (NASDAQ: CCBS) seeks to make NASDAQ debut under the symbol CCBS. The Company...

Via Benzinga

Adagio Files $100M IPO To Take Its COVID-19 Antibody Through Commercialization In 2022 ↗

July 19, 2021

Adagio Therapeutics has filed an initial public offering to raise money to bring its COVID-19 antibody to market. The $100 million IPO will support Phase 2/3 trials...

Via Benzinga

Topics Initial Public Offering

Celularity Closes SPAC Merger With GX Acquisition, Trading Starts Monday ↗

July 16, 2021

Celularity Inc has closed the merger with GX Acquisition Corp (NASDAQ: GXGX), giving Celularity $138 million to push the NK cell and T cell therapies into early-...

Via Benzinga

Alibaba, SoftBank Backed Indian Online Payment Startup Paytm Eyes $2.2B IPO: TechCrunch ↗

July 16, 2021

Indian digital payments startup, Paytm, plans to raise $2.2 billion in an initial public offering, TechCrunch reports. Alibaba Group Holding Ltd (NYSE: BABA) and Ant...

Via Benzinga

Heart Disease Company Tenaya Therapeutics Files For $100M US IPO ↗

July 12, 2021

Tenaya Therapeutics (NASDAQ: TNYA) is quickstepping into a $100 million NASDAQ debut under the TNYA symbol. The company filed an SEC prospectus on Friday. The biotech...

Via Benzinga

Topics Regulatory Compliance

Ocular Medical Device Firm Sight Sciences Sets Terms For $150M IPO ↗

July 09, 2021

Ophthalmic device developer Sight Sciences (NASDAQ: SGHT) hopes to see its way to nearly a $1 billion valuation through a $150 million Nasdaq debut. The IPO includes 7...

Via Benzinga

Topics Initial Public Offering

Precision Oncology-Focused Biotech Nuvalent Files For $100M IPO ↗

July 07, 2021

Less than six months after emerging from stealth, the Deerfield-backed biotech Nuvalent (NASDAQ: NUVL) is already prepping a Nasdaq debut. Nuvalent filed its S-1...

Via Benzinga

Rare Disease Biotech Rallybio Targets $100M IPO ↗

July 06, 2021

Rallybio Corporation (NASDAQ: RLYB) ended the first quarter with nearly $128 million in the bank, and now it has filed to raise up to $100 million in its IPO to...

Via Benzinga

Topics Initial Public Offering

GIC-Backed WCG Clinical Plans $100M NASDAQ Debut ↗

July 02, 2021

WCG Clinical Inc (NASDAQ: WCGC), a clinical trial solutions company backed by Singapore's sovereign wealth fund GIC, filed for an initial public offering in the U.S. on...

Via Benzinga

Caribou Biosciences Eyes $100M NASDAQ Debut To Propel Off-The-Shelf CAR-T Therapies In Blood Cancer ↗

July 02, 2021

In a filing with SEC on Thursday, Caribou Biosciences (NASDAQ: CRBU) is penciling in a $100 million initial public offering. The firm expects that its new shares...

Via Benzinga

Topics Regulatory Compliance

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.